MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Biotechnology_Personalized, Precision, Preemptive Medicines
On-Q-ity
Parents
*Architects: Biotechnology_Personalized, Precision, Preemptive Medicines
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology
2013: Unhealthy Prognosis for Venture-Backed Diagnostics (2013)
WatchList: Closing, Closed, Inactive, Liquidation, Dissolution or Out of Business
Children
2013: On-Q-ity, a Cancer Diagnostic Company: R.I.P. (2013)
and, a circulating tumor cell (CTC) capture and characterization platform.
Cellective Dx
DNA Repair pathway tissue-based biomarkers for drug response prediction in breast and lung cancer
DNAR
Series A round was $26M and had four VCs: Mohr Davidow Ventures led the round (and was the lead investor in the prior entities), and Atlas, Physic, and Bessemer all participated.
Jumps
LabCorp (Laboratory Corporation of America Holdings) _ (NYSE: LH)